{"id":"antimoniate-of-n-methylglucamine","safety":{"commonSideEffects":[{"rate":null,"effect":"Pancreatitis"},{"rate":null,"effect":"Cardiotoxicity"},{"rate":null,"effect":"Nephrotoxicity"},{"rate":null,"effect":"Arthralgia"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Elevated liver enzymes"}]},"_chembl":{"chemblId":"CHEMBL239129","moleculeType":"Small molecule","molecularWeight":"365.98"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug works by penetrating Leishmania parasites and interfering with their glycolytic enzymes and mitochondrial function, leading to parasite death. Pentavalent antimony compounds are reduced to trivalent antimony within the parasite, which then inhibits key metabolic pathways essential for parasite survival. This mechanism makes it effective against various forms of leishmaniasis.","oneSentence":"Antimoniate of N-methylglucamine is a pentavalent antimony compound that kills Leishmania parasites by disrupting their metabolism and energy production.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:17:20.330Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Visceral leishmaniasis"},{"name":"Cutaneous leishmaniasis"},{"name":"Mucocutaneous leishmaniasis"}]},"trialDetails":[{"nctId":"NCT01310738","phase":"PHASE4","title":"Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil","status":"TERMINATED","sponsor":"University of Brasilia","startDate":"2011-02","conditions":"Visceral Leishmaniasis","enrollment":378}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":73,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Glucantime"],"phase":"marketed","status":"active","brandName":"Antimoniate of N-methylglucamine","genericName":"Antimoniate of N-methylglucamine","companyName":"University of Brasilia","companyId":"university-of-brasilia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antimoniate of N-methylglucamine is a pentavalent antimony compound that kills Leishmania parasites by disrupting their metabolism and energy production. Used for Visceral leishmaniasis, Cutaneous leishmaniasis, Mucocutaneous leishmaniasis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}